Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to
Just $1.99per week for the first 24weeks
Just $1.99per week for the first 24weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(}function setPanelState(o){dom.root.classList[o?"add":"remove"](,dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //

Canadians watched with emotion as Gisèle Lévesque became the first person in the country to be vaccinated against COVID-19 on Dec. 14. Seeing the 89-year-old resident of a Quebec City long-term care home receive her first dose of the Pfizer-BioNTech vaccine provided concrete proof of progress against the novel coronavirus that had made 2020 the worst year of our lives. It gave us hope, if not confidence, that we could soon put this pandemic behind us.

Those hopes were quickly dashed, however, when several other residents who had been vaccinated at the CHSLD Sainte-Antoine around the same time as Ms. Lévesque came down with COVID-19. The same thing happened at Montreal’s Maimonides Geriatric Centre, underscoring the rapidity with which the virus continues to spread through long-term care homes in Quebec and other provinces.

Despite the record pace at which vaccines from Pfizer, Moderna and AstraZeneca have gone from the test lab into the arms of millions of people around the world, the sad fact is that vaccination will still come too late for too many before this is all over.

Story continues below advertisement

Dozens of Canadian lives are still being lost daily to COVID-19 as Ottawa and the provinces play the blame game for the snail’s-pace start to vaccination here. The unprecedented nature of this pandemic and the global competition to secure a limited number of vaccine doses made it unrealistic to expect Canada to match the performance of Israel, which has already vaccinated almost one-sixth of its nine million residents. But Ottawa and the provinces will need to up their games fast as Canadians chafe under seemingly endless pandemic restrictions.

Canada’s social fabric appears to have held up relatively well through the first 10 months of this crisis. Nonetheless, countless Canadians have been suffering in silence. The full extent of the disorders caused by the pandemic lockdowns remains hidden from public view. Besides the higher incidence of drug overdoses and depression among adults, the long-term consequences of the pandemic on a generation of school-aged Canadians could haunt society for decades.

The last thing Canadians want to hear from politicians are excuses for a vaccination campaign that has not kept pace with those under way in Britain or the United States. On Tuesday, Prime Minister Justin Trudeau sought to cast blame for the slow vaccine rollout on the provinces, which have administered fewer than half of the more than 420,000 doses that Ottawa has delivered to them. “I think all Canadians, including me, are frustrated to see vaccines in freezers and not in people’s arms,” Mr. Trudeau told reporters.

His response royally ticked off his provincial counterparts. “Instead of giving lessons to the provinces on standards in long-term care homes and on vaccines, he should take care of supplying us with vaccines faster and better control travellers returning to Canada,” Quebec Premier François Legault snapped on Wednesday after announcing an enhanced four-week lockdown that includes a controversial 8 p.m. curfew in the province.

Manitoba Premier Brian Pallister and Ontario Premier Doug Ford have also complained about insufficient vaccine deliveries from Ottawa – Mr. Pallister likened the volume to “a squirt gun” – even though neither province has used up the doses the federal government has provided. Part of the reason for that lies in that the Pfizer vaccine must be stored at between -70C and -80C, creating a particular logistical challenge. An initial decision to hold back required second doses for those who have already received a first dose of the Pfizer vaccine also slowed the rollout. The abandonment of that decision has not gone over well with everyone. A group of residents at Maimonides have threatened legal action against the Quebec government.

No province appears to have adopted particularly ambitious vaccination targets. Mr. Ford has vowed to have administered an initial dose to 55,000 long-term care residents in five hot spot regions by Jan. 21. Quebec aims to vaccinate 250,000 long-term care patients and health care workers by Feb. 8. Yet, Mr. Legault insisted on Wednesday that his province is capable of giving 250,000 vaccines a week. Canadians are right to wonder about the disconnect.

We don’t know whether Ottawa dropped the ball in negotiating vaccine purchases for the simple reason that Public Services and Procurement Canada has released scant details about the terms of contracts signed with Pfizer, Moderna, AstraZeneca and other vaccine makers. Israel, for instance, reportedly paid Pfizer US$30 a dose, compared with the US$19.50 Washington paid as part of the Trump administration’s Operation Warp Speed. Ottawa has not said how much it paid.

Story continues below advertisement

“It’s a very competitive environment around the world, everywhere,” Procurement Minister Anita Anand insisted. “Every country wants to have the same products, the same doses, and so we have to negotiate very hard for Canada to have more doses as soon as possible and that’s the job for me and my team every day.”

Good intentions will no longer cut it with Canadians. From here on in, they want results.

Quebec's Public Safety Minister Geneviève Guilbault says she expects police to use their judgement while enforcing the province's curfew which comes into effect on Saturday evening. The Canadian Press

Keep your Opinions sharp and informed. Get the Opinion newsletter. Sign up today.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow the author of this article:

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to If you want to write a letter to the editor, please forward to

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

UPDATED: Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies